Status and Prospects of Liver Cirrhosis Treatment by Using Bone Marrow-Derived Cells and Mesenchymal Cells-Reference-Cited by-同舟云学术

Status and Prospects of Liver Cirrhosis Treatment by Using Bone Marrow-Derived Cells and Mesenchymal Cells

Published:2014-06 Issue:3 Volume:20 Page:206-210
ISSN:1937-3368
Container-title:Tissue Engineering Part B: Reviews
language:en
Short-container-title:Tissue Engineering Part B: Reviews

Author:

Terai Shuji¹,Takami Taro¹,Yamamoto Naoki²,Fujisawa Koichi³,Ishikawa Tsuyoshi¹,Urata Yohei¹,Tanimoto Haruko¹,Iwamoto Takuya¹,Mizunaga Yuko¹,Matsuda Takashi¹,Oono Takashi¹,Marumoto Miho¹,Burganova Guzel¹⁴⁵,Fernando Quintanilha Luiz¹⁶,Hidaka Isao¹,Marumoto Yoshio¹,Saeki Issei¹,Uchida Koichi¹,Yamasaki Takahiro¹,Tani Kenji⁷,Taura Yasuho⁷,Fujii Yasuhiko⁸,Nishina Hiroshi⁹,Okita Kiwamu¹,Sakaida Isao¹³

Affiliation:

1. Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.

2. Yamaguchi University Health Administration Center, Yamaguchi University, Yamaguchi, Japan.

3. Center for Reparative Medicine, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.

4. Human Anatomy Department, Kazan State Medical University, Kazan, Russia.

5. Institute of Fundamental Medicine and Biology, Kazan (Volga region) Federal University, Kazan, Russian Federation.

6. Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

7. Department of Veterinary Surgery, Faculty of Agriculture, Yamaguchi University, Yamaguchi, Japan.

8. Center of Regenerative Medicine and Cell Therapy, Yamaguchi University Hospital, Yamaguchi, Japan.

9. Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biochemistry,Biomaterials,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.teb.2013.0527

Reference18 articles.

1. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation

2. An In Vivo Model for Monitoring Trans-Differentiation of Bone Marrow Cells into Functional Hepatocytes

3. Lesson from the GFP/CCl4 model — Translational Research Project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis

4. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice

5. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases;Stem Cell Research & Therapy;2023-05-24

2. Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin;Acta Pharmacologica Sinica;2022-07-27

3. ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway;Cell Death Discovery;2022-02-08

4. Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension;Scientific Reports;2021-10-28

5. Clinical and morphological case of developing liver cirrhosis associated with viral hepatitis in a young patient;Russian Journal of Infection and Immunity;2021-09-20